Neural Cell News

Neural Cell News is an online resource covering the latest research in neuroscience, neural stem cells, and neurological conditions.

Subscribe|Follow Us On

New KWF Funding Boosts 8 CCA Cancer Research Projects

August 21, 2026

[Amsterdam UMC] KWF announced 34 research projects that will receive funding in its latest round — including 8 projects involving Cancer Center Amsterdam (CCA) researchers.

Procognitive Restoration of PV Neuron Plasticity in Neurodevelopmental Disorders

August 18, 2026

[Nature] Investigators showed that restoring plasticity in parvalbumin neurons can improve cognition and suppress seizures in a neurodevelopmental disorder model, suggesting that some developmental circuit deficits may be reversible in adulthood.

PLCG2 Downregulation Impairs Synaptic Function and Increases Alzheimer’s Disease Hallmarks in Neuronal Cultures

August 18, 2026

[Nature Genetics] Scientists developed a high-content screening to investigate how Alzheimer’s disease genetic risk factors may affect synaptic mechanisms in rat primary neuronal cultures.

Dendritic Translation and Neuroproteasome-Mediated Degradation of Endogenous Tau Revealed by STARFISH

August 18, 2026

[Nature Neuroscience] Researchers developed STARFISH, a method for visualizing the subcellular site of endogenous mRNA translation in primary neurons and in vivo with single-molecule sensitivity and near-codon resolution, without modifying the nascent polypeptide.

Pleiotrophin Regulates Presynaptic Assembly and Function through Heparan Sulfate-Dependent Binding to Neurexin1

August 18, 2026

[Cell Reports] Scientists identified pleiotrophin (Ptn) as a regulator of presynaptic development. Affinity purification-based proteomics shows that Ptn associates with heparan sulfate (HS)-modified neurexin1 in the brain through an HS-glycan-dependent mechanism.

Long-Term Daily Light Exposure Boosts Human Retinal Organoid Differentiation

August 18, 2026

[Communications Biology] The authors investigated whether daily light exposure promotes photoreceptor maturation by exposing retinal organoids to six hours of daily light starting from day 70 in vitro.

Potential for Enhanced Oncolytic HSV-1 Therapy via SHED As a Vehicle against Malignant Gliomas

August 18, 2026

[Cancer Gene Therapy] Researchers investigated the use of stem cells from human exfoliated deciduous teeth (SHED) as a potential vehicle for oncolytic herpes simplex virus-1 therapy to enhance treatment efficacy.

Tau-Targeting Pharmacological Strategies in Neurodegenerative Disease

August 18, 2026

[Trends in Pharmacological Sciences] The authors review emerging strategies to selectively target pathological tau, from gene silencing and immunotherapy to protein degradation and tau modification, for treating neurodegenerative diseases.

Glial-Neuronal Crosstalk via GABA Signaling: Mechanistic Insights into Neuropsychiatric and Neurological Pathophysiology

August 18, 2026

[Molecular Psychiatry] Scientists summarize current findings on GABA-mediated glial-neuronal crosstalk, with emphasis on its roles in CNS physiology and its multifaceted regulation in neurological and neuropsychiatric disorders.

Neural Regulation of Tumor Immunity: Emerging Opportunities to Enhance Cancer Immunotherapy

August 18, 2026

[Experimental & Molecular Medicine] Investigators highlight how neural signals shape the tumor immune microenvironment, revealing neuroimmune pathways as potential targets to overcome immune evasion and enhance cancer immunotherapy.

Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease

August 18, 2026

[Enigma Biomedical USA (Business Wire)] Enigma Biomedical USA announced the US FDA approval of TAUKLARIFY™, a radiodiagnostic agent indicated for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer’s disease to identify patients with tau neurofibrillary tangle pathology.

UBC Medicine Researchers Awarded More Than $39 Million in CIHR Funding

August 17, 2026

[The University of British Columbia] UBC Faculty of Medicine researchers have been awarded more than $39 million in federal funding through the Canadian Institutes of Health Research (CIHR) Project Grant: Spring 2026 competition.

Neural Cell News helps scientists keep pace with the latest research, reviews, and industry developments in neuroscience. Specific research topics include neural development and neuroregeneration, neural signaling related to cellular responses and behavior, and synaptic plasticity. Research into the diagnosis, progression, cellular characteristics, and treatment of brain diseases such as Parkinson’s, Multiple Sclerosis, Alzheimer’s, Amyotrophic Lateral Sclerosis and various brain cancers, as well as brain damage resulting from infection, trauma, stroke, seizures, and tumors, is also covered.